Decoding the Tumor Microenvironment: Exosome-Mediated Macrophage Polarization and Therapeutic Frontiers

Area of Science:

• Oncology
• Immunology
• Cell Biology

Background:

• The tumor microenvironment (TME) involves complex interactions, with tumor-associated macrophages (TAMs) playing critical roles in cancer progression.
• Exosomes mediate intercellular communication and are vital in regulating macrophage polarization within the TME.
• Hypoxia and endoplasmic reticulum stress (ERS) significantly influence tumor cell behavior and exosome production.

Purpose of the Study:

• To systematically review the role of Hypoxia-inducible factor 1-alpha (HIF-1α) in regulating tumor-derived exosomes under hypoxic conditions.
• To elucidate the molecular pathways (STAT3, PI3K/AKT/mTOR, Hsp90/Hippo) involved in exosome biogenesis and secretion under ERS.
• To evaluate the involvement of TAM-derived exosomes in immune evasion, metastasis, and their interactions with other TME components, and discuss exosome engineering strategies for immunotherapy.

Main Methods:

• Systematic review of existing literature on tumor-derived exosomes, HIF-1α, macrophage polarization, and related signaling pathways.
• Analysis of molecular mechanisms including LncRNA HMMR-AS1, specific miRNAs (miR-1246, let-7a, miR-301a-3p, miR-23a-3p, miR-27a-3p), and PD-L1 expression.
• Evaluation of exosome interactions with immune cells (CD8+ T cells) and stromal components (fibroblasts) within the TME.

Main Results:

• HIF-1α is identified as a central regulator of tumor-derived exosomes under hypoxia.
• ERS activates STAT3 and PI3K/AKT/mTOR pathways via Hsp90/Hippo inactivation, inducing specific lncRNAs and miRNAs that influence exosome content.
• Exosomes carry miRNAs and PD-L1, promoting M2 macrophage polarization, immune evasion, and metastasis; bidirectional crosstalk with TME components is confirmed.

Conclusions:

• Tumor-derived exosomes, particularly those influenced by hypoxia and ERS, are key players in shaping the TME and promoting cancer progression.
• Understanding the molecular regulation of exosome secretion and content is crucial for developing targeted cancer therapies.
• Exosome engineering strategies, combined with advanced omics and AI, hold promise for translating exosomes into effective clinical immunotherapy regimens, though challenges remain.